Stabilized Marine Lipid Extract Coming from New Zealand Green Mussel. Lyprinol ® is a patented oil Green-Lipped Mussel extract of New Zealand (Perna canaliculus) containing a single set of Omega 3 acids Elcosatetraenoicos. Lyprinol ® ensures that each bead contains 50 mg. high purity oil with an extremely active thanks to its patented isolation, stabilization and concentration of natural active ingredients listing process. This product is free of marine protein so it is suitable for people with allergies to shellfish. The characteristic odor and cloudy appearance that may occur in this product are normal and have no effect on quality. Each bead gives 150 mg. fatty acids and 1.3 calories. This product contains no carbohydrates or proteins. Packaging in the EU. Natural marine lipid extract, a powerful anti-inflammatory. A novel patented natural extract of marine lipid stabilized comprising a rare combination of lipid groups and Omega-3 polyunsaturated. Lyprinol ® has been shown through clinical research to be a compound with an extremely potent anti-inflammatory and anti-arthritic activity. This unique marine product has been exposed to critical review by numerous research institutions around the world and after she has demonstrated anti-inflammatory activitysignificantly in vitro to inhibit leukotriene synthesis and in vivo by the marked reduction in severity induced polyarthritis in rats. Several publications have confirmed these results and the recent completion of a double-blind study in humans conducted in Hospital Glasgow in Scotland also confirmed these results. Leukotrienes are formed in the body via the lipoxygenase pathway and are responsible for the initiation and extent of the inflammatory process. The work carried out by the Queen Elizabeth Hospital and the University of Adelaide in Australia have clearly shown that Lyprinol ® stabilized marine lipid is a potent inhibitor of the pathway of 5-lipoxygenase, because this greatly reduces the harmful effects of chronic inflammation that can be found in several allergic reactions such as arthritis and other inflammatory processes such as asthma. Because many of the currently used anti-inflammatory drugs, including nonsteroidal anti-inflammatory drugs NSAIDs, work through the cyclo-oxygenase, much research and recent international efforts have been directed toward the development of inhibitors of the inflammatory pathway second largest satellite, the lipoxygenase. There is little doubt that Lyprinol ® can provide a powerful means to control and inhibit the damage caused by the excesses ofinflammatory responses in the body. In vivo studies undertaken by the University in Australia Quuensland They tested the anti-arthritic properties of Lyprinol ®. Using standard models to evaluate the potency of conventional arthritis drugs, Lyprinol ® ™ was measured against its ability to reduce edema associated with poly arthritis induced in rats. It was published in the journal "Inflammopharmacology". The results were spectacular, Lyprinol ® reduced edema in joints up to 93% compared with untreated control groups. Continuing these remarkable discoveries scientists at the University of Quuensland then focused on comparing Lyprinol ® with two widely used drugs called Indomethacin and Ibuprofen. When it was delivered to the same dose (5 mg / kg-day) exceeded Lyprinol ® drug Indomethacin and Ibuprofen by a ratio of 2:1. This was an amazing successful outcome for Lyprinol ®. More recently, a double-blind clinical trial led by University Hospital NHS West Glasgow involving 60 patients, 30 of whom had classical rheumatoid arthritis and the other 30 with clinical and radiological evidence of osteoarthritis, showed excellent results. Both rheumatic patients as suffering from osteoarthritis showed improvementssignificant estuaries, 76% of rheumatic and 70% of osteoarthritic benefited in the experiment. 79% and 80% respectively when excluding dropouts. These results have been published in the journal "Complementary Therapies in Medicine." (Sept.1998) like A pilot study conducted in Denmark showed that Lyprinol ™ dramatically reduced the level of pain over a period of 2 to 3 months in patients with osteoarthritis. The study is currently being expanded. These findings prompted a series of subsequent studies to evaluate the ability of Lyprinol ® compared with other healthy food products that are attributed also anti-arthritic properties. Lyprinol ® was compared to Flax Oil, Evening Primrose Oil, and Salmon Oil EPA Max (fish) test induced by poly arthritis. Whitehouse Studios - Inflammopharmacology 1 +2 A dose of Lyprinol ® for a body weight basis is 100 times more potent than EPA Max 125 times more potent than powdered Green Lipped Mussel (not concentrated) 175 times more potent than oil Primrose 175 times more potent than Salmon Oil and 200 times more potent than Flax Oil in the regulation of inflammation associated with arthritis edematous
Do you like this product?
All our products are sent with full guarantees and security. Shipping to Barcelona / Catalonia 4 €, Rest of Spain and Portugal 6 €. Europe, America and the rest of the world since 14,00 €. See all our conditions conditions*
You have 14 days to return your order from the date of arrival at your home. We guarantee a refund of the amount paid for products returned of your order. Display all details of our return policy.